Loading…

An evaluation of the diagnostic equivalence of 18F-FDG-PET between hybrid PET/MRI and PET/CT in drug-resistant epilepsy: A pilot study

•Visual assessments of PET/MRI and PET/CT images were similar and yielded comparable diagnostic outcome in our DRE cohort.•Quantitative FDG-PET bias between PET/MRI and PET/CT was low and of no practical significance.•PET/MRI with optimal brain MRAC can yield similar diagnostic performance as PET/CT...

Full description

Saved in:
Bibliographic Details
Published in:Epilepsy research 2021-05, Vol.172, p.106583-106583, Article 106583
Main Authors: Poirier, Stefan E., Kwan, Benjamin Y.M., Jurkiewicz, Michael T., Samargandy, Lina, Iacobelli, Maryssa, Steven, David A., Lam Shin Cheung, Victor, Moran, Gerald, Prato, Frank S., Thompson, R. Terry, Burneo, Jorge G., Anazodo, Udunna C., Thiessen, Jonathan D.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c1963-b6991876dfcbd72297cadebbf140fd2b95ac2bf9268c0d948e1143cd6d9886963
cites cdi_FETCH-LOGICAL-c1963-b6991876dfcbd72297cadebbf140fd2b95ac2bf9268c0d948e1143cd6d9886963
container_end_page 106583
container_issue
container_start_page 106583
container_title Epilepsy research
container_volume 172
creator Poirier, Stefan E.
Kwan, Benjamin Y.M.
Jurkiewicz, Michael T.
Samargandy, Lina
Iacobelli, Maryssa
Steven, David A.
Lam Shin Cheung, Victor
Moran, Gerald
Prato, Frank S.
Thompson, R. Terry
Burneo, Jorge G.
Anazodo, Udunna C.
Thiessen, Jonathan D.
description •Visual assessments of PET/MRI and PET/CT images were similar and yielded comparable diagnostic outcome in our DRE cohort.•Quantitative FDG-PET bias between PET/MRI and PET/CT was low and of no practical significance.•PET/MRI with optimal brain MRAC can yield similar diagnostic performance as PET/CT.•Hybrid PET/MRI can reliably detect SOZ in DRE and is a promising tool for enhancing epilepsy treatment and management. Hybrid PET/MRI may improve detection of seizure-onset zone (SOZ) in drug-resistant epilepsy (DRE), however, concerns over PET bias from MRI-based attenuation correction (MRAC) have limited clinical adoption of PET/MRI. This study evaluated the diagnostic equivalency and potential clinical value of PET/MRI against PET/CT in DRE. MRI, FDG-PET and CT images (n = 18) were acquired using a hybrid PET/MRI and a CT scanner. To assess diagnostic equivalency, PET was reconstructed using MRAC (RESOLUTE) and CT-based attenuation correction (CTAC) to generate PET/MRI and PET/CT images, respectively. PET/MRI and PET/CT images were compared qualitatively through visual assessment and quantitatively through regional standardized uptake value (SUV) and z-score assessment. Diagnostic accuracy and sensitivity of PET/MRI and PET/CT for SOZ detection were calculated through comparison to reference standards (clinical hypothesis and histopathology, respectively). Inter-reader agreement in visual assessment of PET/MRI and PET/CT images was 78 % and 81 %, respectively. PET/MRI and PET/CT were strongly correlated in mean SUV (r = 0.99, p < 0.001) and z-scores (r = 0.92, p < 0.001) across all brain regions. MRAC SUV bias was
doi_str_mv 10.1016/j.eplepsyres.2021.106583
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2494276143</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S092012112100036X</els_id><sourcerecordid>2494276143</sourcerecordid><originalsourceid>FETCH-LOGICAL-c1963-b6991876dfcbd72297cadebbf140fd2b95ac2bf9268c0d948e1143cd6d9886963</originalsourceid><addsrcrecordid>eNqFkMFuGyEQhlHUSHGTvAPHXNYGTFjozXXtNJKrRJV7RizMJlgbdg1sKr9An7u4W6nHnmY0M_-vfz6EMCVzSqhYHOYwdDCkU4Q0Z4TRMhb3cnmBZlTWrBKS8w9oRhQjFWWUXqGPKR0IITXhfIZ-rQKGd9ONJvs-4L7F-RWw8-Yl9Cl7i-E4-rKHYOG8pXJbbb88VM-bPW4g_wQI-PXURO9wGS2-fX_EJkz9eo99wC6OL1XJ5lM2IWMY_J-0n_AKl7bPOOXRnW7QZWu6BLd_6zX6sd3s11-r3dPD43q1qyxVYlk1QqnylXCtbVzNmKqtcdA0LeWkdaxR98ayplVMSEuc4hIo5UvrhFNSiuJwje4m3yH2xxFS1m8-Weg6E6Afk2ZccVaLIiqncjq1sU8pQquH6N9MPGlK9Bm9Puh_6PUZvZ7QF-nnSQrllXcPUSfrzwSdj2Czdr3_v8lvP4WSBw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2494276143</pqid></control><display><type>article</type><title>An evaluation of the diagnostic equivalence of 18F-FDG-PET between hybrid PET/MRI and PET/CT in drug-resistant epilepsy: A pilot study</title><source>ScienceDirect Freedom Collection</source><creator>Poirier, Stefan E. ; Kwan, Benjamin Y.M. ; Jurkiewicz, Michael T. ; Samargandy, Lina ; Iacobelli, Maryssa ; Steven, David A. ; Lam Shin Cheung, Victor ; Moran, Gerald ; Prato, Frank S. ; Thompson, R. Terry ; Burneo, Jorge G. ; Anazodo, Udunna C. ; Thiessen, Jonathan D.</creator><creatorcontrib>Poirier, Stefan E. ; Kwan, Benjamin Y.M. ; Jurkiewicz, Michael T. ; Samargandy, Lina ; Iacobelli, Maryssa ; Steven, David A. ; Lam Shin Cheung, Victor ; Moran, Gerald ; Prato, Frank S. ; Thompson, R. Terry ; Burneo, Jorge G. ; Anazodo, Udunna C. ; Thiessen, Jonathan D.</creatorcontrib><description>•Visual assessments of PET/MRI and PET/CT images were similar and yielded comparable diagnostic outcome in our DRE cohort.•Quantitative FDG-PET bias between PET/MRI and PET/CT was low and of no practical significance.•PET/MRI with optimal brain MRAC can yield similar diagnostic performance as PET/CT.•Hybrid PET/MRI can reliably detect SOZ in DRE and is a promising tool for enhancing epilepsy treatment and management. Hybrid PET/MRI may improve detection of seizure-onset zone (SOZ) in drug-resistant epilepsy (DRE), however, concerns over PET bias from MRI-based attenuation correction (MRAC) have limited clinical adoption of PET/MRI. This study evaluated the diagnostic equivalency and potential clinical value of PET/MRI against PET/CT in DRE. MRI, FDG-PET and CT images (n = 18) were acquired using a hybrid PET/MRI and a CT scanner. To assess diagnostic equivalency, PET was reconstructed using MRAC (RESOLUTE) and CT-based attenuation correction (CTAC) to generate PET/MRI and PET/CT images, respectively. PET/MRI and PET/CT images were compared qualitatively through visual assessment and quantitatively through regional standardized uptake value (SUV) and z-score assessment. Diagnostic accuracy and sensitivity of PET/MRI and PET/CT for SOZ detection were calculated through comparison to reference standards (clinical hypothesis and histopathology, respectively). Inter-reader agreement in visual assessment of PET/MRI and PET/CT images was 78 % and 81 %, respectively. PET/MRI and PET/CT were strongly correlated in mean SUV (r = 0.99, p &lt; 0.001) and z-scores (r = 0.92, p &lt; 0.001) across all brain regions. MRAC SUV bias was &lt;5% in most brain regions except the inferior temporal gyrus, temporal pole, and cerebellum. Diagnostic accuracy and sensitivity were similar between PET/MRI and PET/CT (87 % vs. 85 % and 83 % vs. 83 %, respectively). We demonstrate here that PET/MRI with optimal MRAC can yield similar diagnostic performance as PET/CT. Nevertheless, further exploration of the potential added value of PET/MRI is necessary before clinical adoption of PET/MRI for epilepsy imaging.</description><identifier>ISSN: 0920-1211</identifier><identifier>EISSN: 1872-6844</identifier><identifier>DOI: 10.1016/j.eplepsyres.2021.106583</identifier><language>eng</language><publisher>Elsevier B.V</publisher><subject>Drug-resistant epilepsy ; Fluorodeoxyglucose ; MRI-based attenuation correction ; PET/CT ; PET/MRI</subject><ispartof>Epilepsy research, 2021-05, Vol.172, p.106583-106583, Article 106583</ispartof><rights>2021 Elsevier B.V.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c1963-b6991876dfcbd72297cadebbf140fd2b95ac2bf9268c0d948e1143cd6d9886963</citedby><cites>FETCH-LOGICAL-c1963-b6991876dfcbd72297cadebbf140fd2b95ac2bf9268c0d948e1143cd6d9886963</cites><orcidid>0000-0002-4592-2522 ; 0000-0002-0392-8950 ; 0000-0002-0666-7952 ; 0000-0001-8864-035X ; 0000-0002-6290-5505 ; 0000-0002-4326-9275 ; 0000-0002-1124-3206 ; 0000-0001-6132-3020 ; 0000-0002-4641-3172</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27903,27904</link.rule.ids></links><search><creatorcontrib>Poirier, Stefan E.</creatorcontrib><creatorcontrib>Kwan, Benjamin Y.M.</creatorcontrib><creatorcontrib>Jurkiewicz, Michael T.</creatorcontrib><creatorcontrib>Samargandy, Lina</creatorcontrib><creatorcontrib>Iacobelli, Maryssa</creatorcontrib><creatorcontrib>Steven, David A.</creatorcontrib><creatorcontrib>Lam Shin Cheung, Victor</creatorcontrib><creatorcontrib>Moran, Gerald</creatorcontrib><creatorcontrib>Prato, Frank S.</creatorcontrib><creatorcontrib>Thompson, R. Terry</creatorcontrib><creatorcontrib>Burneo, Jorge G.</creatorcontrib><creatorcontrib>Anazodo, Udunna C.</creatorcontrib><creatorcontrib>Thiessen, Jonathan D.</creatorcontrib><title>An evaluation of the diagnostic equivalence of 18F-FDG-PET between hybrid PET/MRI and PET/CT in drug-resistant epilepsy: A pilot study</title><title>Epilepsy research</title><description>•Visual assessments of PET/MRI and PET/CT images were similar and yielded comparable diagnostic outcome in our DRE cohort.•Quantitative FDG-PET bias between PET/MRI and PET/CT was low and of no practical significance.•PET/MRI with optimal brain MRAC can yield similar diagnostic performance as PET/CT.•Hybrid PET/MRI can reliably detect SOZ in DRE and is a promising tool for enhancing epilepsy treatment and management. Hybrid PET/MRI may improve detection of seizure-onset zone (SOZ) in drug-resistant epilepsy (DRE), however, concerns over PET bias from MRI-based attenuation correction (MRAC) have limited clinical adoption of PET/MRI. This study evaluated the diagnostic equivalency and potential clinical value of PET/MRI against PET/CT in DRE. MRI, FDG-PET and CT images (n = 18) were acquired using a hybrid PET/MRI and a CT scanner. To assess diagnostic equivalency, PET was reconstructed using MRAC (RESOLUTE) and CT-based attenuation correction (CTAC) to generate PET/MRI and PET/CT images, respectively. PET/MRI and PET/CT images were compared qualitatively through visual assessment and quantitatively through regional standardized uptake value (SUV) and z-score assessment. Diagnostic accuracy and sensitivity of PET/MRI and PET/CT for SOZ detection were calculated through comparison to reference standards (clinical hypothesis and histopathology, respectively). Inter-reader agreement in visual assessment of PET/MRI and PET/CT images was 78 % and 81 %, respectively. PET/MRI and PET/CT were strongly correlated in mean SUV (r = 0.99, p &lt; 0.001) and z-scores (r = 0.92, p &lt; 0.001) across all brain regions. MRAC SUV bias was &lt;5% in most brain regions except the inferior temporal gyrus, temporal pole, and cerebellum. Diagnostic accuracy and sensitivity were similar between PET/MRI and PET/CT (87 % vs. 85 % and 83 % vs. 83 %, respectively). We demonstrate here that PET/MRI with optimal MRAC can yield similar diagnostic performance as PET/CT. Nevertheless, further exploration of the potential added value of PET/MRI is necessary before clinical adoption of PET/MRI for epilepsy imaging.</description><subject>Drug-resistant epilepsy</subject><subject>Fluorodeoxyglucose</subject><subject>MRI-based attenuation correction</subject><subject>PET/CT</subject><subject>PET/MRI</subject><issn>0920-1211</issn><issn>1872-6844</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><recordid>eNqFkMFuGyEQhlHUSHGTvAPHXNYGTFjozXXtNJKrRJV7RizMJlgbdg1sKr9An7u4W6nHnmY0M_-vfz6EMCVzSqhYHOYwdDCkU4Q0Z4TRMhb3cnmBZlTWrBKS8w9oRhQjFWWUXqGPKR0IITXhfIZ-rQKGd9ONJvs-4L7F-RWw8-Yl9Cl7i-E4-rKHYOG8pXJbbb88VM-bPW4g_wQI-PXURO9wGS2-fX_EJkz9eo99wC6OL1XJ5lM2IWMY_J-0n_AKl7bPOOXRnW7QZWu6BLd_6zX6sd3s11-r3dPD43q1qyxVYlk1QqnylXCtbVzNmKqtcdA0LeWkdaxR98ayplVMSEuc4hIo5UvrhFNSiuJwje4m3yH2xxFS1m8-Weg6E6Afk2ZccVaLIiqncjq1sU8pQquH6N9MPGlK9Bm9Puh_6PUZvZ7QF-nnSQrllXcPUSfrzwSdj2Czdr3_v8lvP4WSBw</recordid><startdate>202105</startdate><enddate>202105</enddate><creator>Poirier, Stefan E.</creator><creator>Kwan, Benjamin Y.M.</creator><creator>Jurkiewicz, Michael T.</creator><creator>Samargandy, Lina</creator><creator>Iacobelli, Maryssa</creator><creator>Steven, David A.</creator><creator>Lam Shin Cheung, Victor</creator><creator>Moran, Gerald</creator><creator>Prato, Frank S.</creator><creator>Thompson, R. Terry</creator><creator>Burneo, Jorge G.</creator><creator>Anazodo, Udunna C.</creator><creator>Thiessen, Jonathan D.</creator><general>Elsevier B.V</general><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-4592-2522</orcidid><orcidid>https://orcid.org/0000-0002-0392-8950</orcidid><orcidid>https://orcid.org/0000-0002-0666-7952</orcidid><orcidid>https://orcid.org/0000-0001-8864-035X</orcidid><orcidid>https://orcid.org/0000-0002-6290-5505</orcidid><orcidid>https://orcid.org/0000-0002-4326-9275</orcidid><orcidid>https://orcid.org/0000-0002-1124-3206</orcidid><orcidid>https://orcid.org/0000-0001-6132-3020</orcidid><orcidid>https://orcid.org/0000-0002-4641-3172</orcidid></search><sort><creationdate>202105</creationdate><title>An evaluation of the diagnostic equivalence of 18F-FDG-PET between hybrid PET/MRI and PET/CT in drug-resistant epilepsy: A pilot study</title><author>Poirier, Stefan E. ; Kwan, Benjamin Y.M. ; Jurkiewicz, Michael T. ; Samargandy, Lina ; Iacobelli, Maryssa ; Steven, David A. ; Lam Shin Cheung, Victor ; Moran, Gerald ; Prato, Frank S. ; Thompson, R. Terry ; Burneo, Jorge G. ; Anazodo, Udunna C. ; Thiessen, Jonathan D.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c1963-b6991876dfcbd72297cadebbf140fd2b95ac2bf9268c0d948e1143cd6d9886963</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Drug-resistant epilepsy</topic><topic>Fluorodeoxyglucose</topic><topic>MRI-based attenuation correction</topic><topic>PET/CT</topic><topic>PET/MRI</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Poirier, Stefan E.</creatorcontrib><creatorcontrib>Kwan, Benjamin Y.M.</creatorcontrib><creatorcontrib>Jurkiewicz, Michael T.</creatorcontrib><creatorcontrib>Samargandy, Lina</creatorcontrib><creatorcontrib>Iacobelli, Maryssa</creatorcontrib><creatorcontrib>Steven, David A.</creatorcontrib><creatorcontrib>Lam Shin Cheung, Victor</creatorcontrib><creatorcontrib>Moran, Gerald</creatorcontrib><creatorcontrib>Prato, Frank S.</creatorcontrib><creatorcontrib>Thompson, R. Terry</creatorcontrib><creatorcontrib>Burneo, Jorge G.</creatorcontrib><creatorcontrib>Anazodo, Udunna C.</creatorcontrib><creatorcontrib>Thiessen, Jonathan D.</creatorcontrib><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Epilepsy research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Poirier, Stefan E.</au><au>Kwan, Benjamin Y.M.</au><au>Jurkiewicz, Michael T.</au><au>Samargandy, Lina</au><au>Iacobelli, Maryssa</au><au>Steven, David A.</au><au>Lam Shin Cheung, Victor</au><au>Moran, Gerald</au><au>Prato, Frank S.</au><au>Thompson, R. Terry</au><au>Burneo, Jorge G.</au><au>Anazodo, Udunna C.</au><au>Thiessen, Jonathan D.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>An evaluation of the diagnostic equivalence of 18F-FDG-PET between hybrid PET/MRI and PET/CT in drug-resistant epilepsy: A pilot study</atitle><jtitle>Epilepsy research</jtitle><date>2021-05</date><risdate>2021</risdate><volume>172</volume><spage>106583</spage><epage>106583</epage><pages>106583-106583</pages><artnum>106583</artnum><issn>0920-1211</issn><eissn>1872-6844</eissn><abstract>•Visual assessments of PET/MRI and PET/CT images were similar and yielded comparable diagnostic outcome in our DRE cohort.•Quantitative FDG-PET bias between PET/MRI and PET/CT was low and of no practical significance.•PET/MRI with optimal brain MRAC can yield similar diagnostic performance as PET/CT.•Hybrid PET/MRI can reliably detect SOZ in DRE and is a promising tool for enhancing epilepsy treatment and management. Hybrid PET/MRI may improve detection of seizure-onset zone (SOZ) in drug-resistant epilepsy (DRE), however, concerns over PET bias from MRI-based attenuation correction (MRAC) have limited clinical adoption of PET/MRI. This study evaluated the diagnostic equivalency and potential clinical value of PET/MRI against PET/CT in DRE. MRI, FDG-PET and CT images (n = 18) were acquired using a hybrid PET/MRI and a CT scanner. To assess diagnostic equivalency, PET was reconstructed using MRAC (RESOLUTE) and CT-based attenuation correction (CTAC) to generate PET/MRI and PET/CT images, respectively. PET/MRI and PET/CT images were compared qualitatively through visual assessment and quantitatively through regional standardized uptake value (SUV) and z-score assessment. Diagnostic accuracy and sensitivity of PET/MRI and PET/CT for SOZ detection were calculated through comparison to reference standards (clinical hypothesis and histopathology, respectively). Inter-reader agreement in visual assessment of PET/MRI and PET/CT images was 78 % and 81 %, respectively. PET/MRI and PET/CT were strongly correlated in mean SUV (r = 0.99, p &lt; 0.001) and z-scores (r = 0.92, p &lt; 0.001) across all brain regions. MRAC SUV bias was &lt;5% in most brain regions except the inferior temporal gyrus, temporal pole, and cerebellum. Diagnostic accuracy and sensitivity were similar between PET/MRI and PET/CT (87 % vs. 85 % and 83 % vs. 83 %, respectively). We demonstrate here that PET/MRI with optimal MRAC can yield similar diagnostic performance as PET/CT. Nevertheless, further exploration of the potential added value of PET/MRI is necessary before clinical adoption of PET/MRI for epilepsy imaging.</abstract><pub>Elsevier B.V</pub><doi>10.1016/j.eplepsyres.2021.106583</doi><tpages>1</tpages><orcidid>https://orcid.org/0000-0002-4592-2522</orcidid><orcidid>https://orcid.org/0000-0002-0392-8950</orcidid><orcidid>https://orcid.org/0000-0002-0666-7952</orcidid><orcidid>https://orcid.org/0000-0001-8864-035X</orcidid><orcidid>https://orcid.org/0000-0002-6290-5505</orcidid><orcidid>https://orcid.org/0000-0002-4326-9275</orcidid><orcidid>https://orcid.org/0000-0002-1124-3206</orcidid><orcidid>https://orcid.org/0000-0001-6132-3020</orcidid><orcidid>https://orcid.org/0000-0002-4641-3172</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 0920-1211
ispartof Epilepsy research, 2021-05, Vol.172, p.106583-106583, Article 106583
issn 0920-1211
1872-6844
language eng
recordid cdi_proquest_miscellaneous_2494276143
source ScienceDirect Freedom Collection
subjects Drug-resistant epilepsy
Fluorodeoxyglucose
MRI-based attenuation correction
PET/CT
PET/MRI
title An evaluation of the diagnostic equivalence of 18F-FDG-PET between hybrid PET/MRI and PET/CT in drug-resistant epilepsy: A pilot study
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-22T16%3A32%3A40IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=An%20evaluation%20of%20the%20diagnostic%20equivalence%20of%2018F-FDG-PET%20between%20hybrid%20PET/MRI%20and%20PET/CT%20in%20drug-resistant%20epilepsy:%20A%20pilot%20study&rft.jtitle=Epilepsy%20research&rft.au=Poirier,%20Stefan%20E.&rft.date=2021-05&rft.volume=172&rft.spage=106583&rft.epage=106583&rft.pages=106583-106583&rft.artnum=106583&rft.issn=0920-1211&rft.eissn=1872-6844&rft_id=info:doi/10.1016/j.eplepsyres.2021.106583&rft_dat=%3Cproquest_cross%3E2494276143%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c1963-b6991876dfcbd72297cadebbf140fd2b95ac2bf9268c0d948e1143cd6d9886963%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2494276143&rft_id=info:pmid/&rfr_iscdi=true